Immunological changes during treatment interruptions: risk factors and clinical sequelae

AIDS. 2003 Jan 3;17(1):126-8. doi: 10.1097/01.aids.0000042587.93174.83.
No abstract available

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count*
  • Disease Progression
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Risk Factors
  • Viral Load

Substances

  • Anti-HIV Agents